Cat. No. 2942
Alternative Name: PD 156707
Chemical Name: 3-(1,3-Benzodioxol-5-yl)-5-hydroxy-
Biological ActivityHighly selective, orally active, non-peptide endothelin-A receptor (ETA) antagonist (IC50 values are 0.3 and 480 nM for ETA and ETB receptors respectively). Antihypertensive; blocks ET-1-induced pressor responses following oral administration.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Coe et al (2002) The endothelin A receptor antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in ther perinatal lamb. J.Pharmacol.Exp.Ther. 302 672. PMID: 12130731.
Jones et al (1999) The effect of the endothelin ETA receptor antagonist CI-1020 on hypoxic pulmonary vasoconstriction. Eur.J.Pharmacol. 374 367. PMID: 10422781.
Doherty et al (1995) Discovery of a novel series of orally active non-peptide endothelin-A (ETA) receptor-selective antagonists. J.Med.Chem. 38 1259. PMID: 7731010.
If you know of a relevant reference for CI 1020 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses CI 1020 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: CI 1020, supplier, selective, orally, active, ETA, antagonists, Receptors, Endothelin, CI1020, Pfizer, PD156707, Tocris Bioscience, ETA Receptor Antagonist products
Find multiple products by catalog number
New Products in this Area
High affinity dual ETA and ETB receptor antagonist;orally bioavailable
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.